1, 5 til 1, 7 gange hurtigere hos pædiatriske patienter over 2 år end hos voksne forsøgspersoner.
Across dose groups, ritonavir oral clearance (CL/F/m2) was approximately 1.5 to 1.7 times faster in paediatric patients above 2 years of age than in adult subjects.